Literature DB >> 20715102

High-throughput live-cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts.

Emilie Flaberg1, Laszlo Markasz, Gabor Petranyi, Gyorgy Stuber, Ferenc Dicso, Nidal Alchihabi, Èva Oláh, István Csízy, Tamás Józsa, Ove Andrén, Jan-Erik Johansson, Swen-Olof Andersson, George Klein, Laszlo Szekely.   

Abstract

Increasing evidence indicates that cancer development requires changes both in the precancerous cells and in their microenvironment. To study one aspect of the microenvironmental control, we departed from Michael Stoker's observation (Stroker et al, J Cell Sci 1966;1:297-310) that normal fibroblasts can inhibit the growth of admixed cancer cells (neighbour suppression). We have developed a high-throughput microscopy and image analysis system permitting the examination of live mixed cell cultures growing on 384-well plates, at the single cell level and over time. We have tested the effect of 107 samples of low passage number (<5) primary human fibroblasts from pediatric and adult donors, on the growth of six human tumor cell lines. Three of the lines were derived from prostate carcinomas, two from lung carcinomas and one was an EBV transformed lymphoblastoid line. Labeled tumor cells were grown in the presence of unlabeled fibroblasts. The majority of the tested fibroblasts inhibited the proliferation of the tumor cells, compared to the control cultures where labeled tumor cells were co-cultured with unlabeled tumor cells. The proliferation inhibiting effect of the fibroblasts differed depending on their site of origin and the age of the donor. Inhibition required direct cell contact. Mouse 3T3 fibroblasts inhibited the growth of SV40-transformed 3T3 cells and human tumor cells, showing that the inhibitory effect could prevail across the species barrier. Our high-throughput system allows the quantitative analysis of the inhibitory effect of fibroblasts on the population level and the exploration of differences depending on the source of the normal cells.

Entities:  

Mesh:

Year:  2010        PMID: 20715102     DOI: 10.1002/ijc.25612

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  43 in total

Review 1.  The rise and fall of central dogmas.

Authors:  George Klein; Eva Klein
Journal:  Oncoimmunology       Date:  2016-09-26       Impact factor: 8.110

2.  Therapies Targeting the Tumor Stroma and the VEGF/VEGFR Axis in Pancreatic Ductal Adenocarcinoma: a Systematic Review and Meta-Analysis.

Authors:  Zipeng Lu; Maximilian Weniger; Kuirong Jiang; Stefan Boeck; Kai Zhang; Alexander Bazhin; Yi Miao; Jens Werner; Jan G D'Haese
Journal:  Target Oncol       Date:  2018-08       Impact factor: 4.493

3.  Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependent.

Authors:  Twana Alkasalias; Emilie Flaberg; Vladimir Kashuba; Andrey Alexeyenko; Tatiana Pavlova; Andrii Savchenko; Laszlo Szekely; George Klein; Hayrettin Guven
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

Review 4.  Regulation of invadopodia by the tumor microenvironment.

Authors:  Christine M Gould; Sara A Courtneidge
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

Review 5.  Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer.

Authors:  Isaiah G Schauer; Anil K Sood; Samuel Mok; Jinsong Liu
Journal:  Neoplasia       Date:  2011-05       Impact factor: 5.715

Review 6.  Fibroblasts, an inconspicuous but essential player in colon cancer development and progression.

Authors:  Naofumi Mukaida; Soichiro Sasaki
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

7.  Arachidonate 12-lipoxygenase and 12-hydroxyeicosatetraenoic acid contribute to stromal aging-induced progression of pancreatic cancer.

Authors:  Ehab H Sarsour; Jyung Mean Son; Amanda L Kalen; Wusheng Xiao; Juan Du; Matthew S Alexander; Brianne R O'Leary; Joseph J Cullen; Prabhat C Goswami
Journal:  J Biol Chem       Date:  2020-04-07       Impact factor: 5.157

8.  Fibroblasts prolong serum prostate-specific antigen decline after androgen deprivation therapy in prostate cancer.

Authors:  Takeshi Sasaki; Kenichiro Ishii; Yoichi Iwamoto; Manabu Kato; Manabu Miki; Hideki Kanda; Kiminobu Arima; Taizo Shiraishi; Yoshiki Sugimura
Journal:  Lab Invest       Date:  2015-12-07       Impact factor: 5.662

Review 9.  Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?

Authors:  Ellen Puré; Albert Lo
Journal:  Cancer Immunol Res       Date:  2016-04       Impact factor: 11.151

10.  Prostate cancer cells specifically reorganize epithelial cell-fibroblast communication through proteoglycan and junction pathways.

Authors:  Anastasia V Suhovskih; Vladimir I Kashuba; George Klein; Elvira V Grigorieva
Journal:  Cell Adh Migr       Date:  2016-04-25       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.